Henry Hudson Lindner

Dr. Henry Hudson Lindner

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2025 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
HLHenry Hudson Lindner
Henry Hudson Lindner
The 2012 American endocrine associations' guidelines on hypothyroidism were a reiteration of the TSH-T4 Paradigm from the 1970s. They likewise defined hypothyroidism as hypothyroxinemia, assumed that almost all hypothyroidism was primary, and relied upon the thyroid stimulating hormone (TSH) test and inactive prohormone thyroxine (T4) for diagnosis and treatment. The guidelines’ authors acknowledged many TSH and other “pitfalls” in the paradigm yet warned physicians against attending to patients’ signs and symptoms and relative free T4 (FT4) and free triiodothyronine (FT3) levels—the only means by which to identify and avoid all pitfalls and provide individualized diagnosis and treatment. This inadequate paradigm has distorted medical practice and research for 50 years, including laboratories’ FT4 and FT3 reference ranges. It produces overdiagnosis, underdiagnosis, inadequate treatment, and widespread patient dissatisfaction. Since the 1970s, our understanding of thyroid hormone production, transport, metabolism, reception, and signaling has increased greatly, as has our appreciation of the importance of optimal T3 effects for health and wellbeing. Hypothyroidism must be defined physiologically as insufficient T3 effect in some or all tissues. The best indicators of tissue T3 effect are the patient’s signs and symptoms, and the best serum tests are FT4 and FT3, considered together. The TSH level is not a reliable indicator of T3 status in the untreated state and is oversuppressed by the peak levels that occur with once-daily oral T4 and/or T3. Normalizing an elevated TSH or low FT4 with T4 usually does not produce sufficient, let alone optimal, T3 effect and can leave some patients markedly hypothyroid. T4/T3 combination therapy is more physiological and effective than T4 monotherapy and must be guided by clinical criteria, not the TSH. Some patients cannot tolerate more T3 effect due to hypocortisolism, inflammation, and other disorders. There is no substitute for the practice of fully informed clinical medicine.

14 August 2025 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
HLHenry Hudson Lindner
Henry Hudson Lindner
Correction on: Lindner HH (2025) Clinical thyroidology: beyond the 1970s’ TSH-T4 Paradigm. Front. Endocrinol. 16:1529791. doi: 10.3389/fendo.2025.1529791In the published article, there was an error. A correction has been made to the last sentence of section 1 Introduction, paragraph 1. This sentence previously stated: “Optimal T3 effect is essential to every aspect of human development, health, and vitality, including the function of the rest of the immune system.” The corrected sentence appears below:“Optimal T3 effect is essential to every aspect of human development, health, and vitality, including the function of the rest of the endocrine system.”The publisher apologizes for this error and states that this does not change the scientific conclusions of the article in any way. The original article has been updated.

27 July 2026 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
Edward BreitschwerdtEdward Breitschwerdt
Edward Breitschwerdt
CRCynthia Robveille
Cynthia Robveille
RMRicardo G Maggi
Ricardo G Maggi
HLHenry Hudson Lindner
Henry Hudson Lindner
BHBrent T. Harris
Brent T. Harris
EKEmily Marie Kingston
Emily Marie Kingston
Background: Vector-borne diseases represent an emerging global threat to public health, yet the potential role of flea and tick-borne pathogens as a cause or cofactor in neuropsychiatric illnesses and suicidal ideation remains relatively uninvestigated. Co-infections with vector-borne Babesia and Bartonella spp., as well as infection with more than one Babesia species, may represent a more important cause of neurological and neuropsychiatric illnesses than is currently appreciated. Methods: Postmortem blood, tissue, and urine samples from six chronically ill youths who ended or wanted to end their lives were tested for molecular evidence of Babesia, Bartonella , and Borrelia spp. using qPCR, dPCR, and enrichment blood culture. Results: Infections with Babesia , Bartonella , or both genera were confirmed by DNA sequencing in five of six subjects. Three different Babesia spp. were detected in four subjects, of whom two were infected with more than one Babesia sp. All six had equivocal Bartonella spp. dPCR + or enrichment culture dPCR + results. Bartonella henselae was confirmed by DNA sequencing in two individuals. Borrelia dPCR was equivocally positive in one subject but could not be confirmed by DNA sequencing. Conclusions: These findings support the hypothesis that persistent Bartonella and Babesia spp. infections may have a causal role in chronic illness and potentially suicidality in young people. More research is needed to determine the prevalence and role of these pathogens in patients with chronic physical and neuropsychiatric symptoms and suicidal ideation.